• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶与癌症特征:调控癌细胞进化的复杂相互作用。

Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution.

作者信息

Kumar Naveen, Sethi Gautam

机构信息

Institute of Molecular and Cell Biology (IMCB), A*STAR (Agency for Science, Technology and Research), Singapore, 138673, Singapore.

Department of Pharmacology and NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117600, Singapore.

出版信息

Cancer Lett. 2023 Dec 1;578:216459. doi: 10.1016/j.canlet.2023.216459. Epub 2023 Oct 19.

DOI:10.1016/j.canlet.2023.216459
PMID:37863351
Abstract

Transformed cells must acquire specific characteristics to be malignant. Weinberg and Hanahan characterize these characteristics as cancer hallmarks. Though these features are independently driven, substantial signaling crosstalk in transformed cells efficiently promotes these feature acquisitions. Telomerase is an enzyme complex that maintains telomere length. However, its main component, Telomere reverse transcriptase (TERT), has been found to interact with various signaling molecules like cMYC, NF-kB, BRG1 and cooperate in transcription and metabolic reprogramming, acting as a strong proponent of malignant features such as cell death resistance, sustained proliferation, angiogenesis activation, and metastasis, among others. It allows cells to avoid replicative senescence and achieve endless replicative potential. This review summarizes both the canonical and noncanonical functions of TERT and discusses how they promote cancer hallmarks. Understanding the role of Telomerase in promoting cancer hallmarks provides vital insight into the underlying mechanism of cancer genesis and progression and telomerase intervention as a possible therapeutic target for cancer treatment. More investigation into the precise molecular mechanisms of telomerase-mediated impacts on cancer hallmarks will contribute to developing more focused and customized cancer treatment methods.

摘要

转化细胞必须获得特定特征才能具有恶性。温伯格和哈纳汉将这些特征描述为癌症标志。尽管这些特征是由独立驱动的,但转化细胞中大量的信号串扰有效地促进了这些特征的获得。端粒酶是一种维持端粒长度的酶复合物。然而,其主要成分端粒逆转录酶(TERT)已被发现与多种信号分子如cMYC、NF-κB、BRG1相互作用,并在转录和代谢重编程中协同作用,作为细胞抗死亡、持续增殖、血管生成激活和转移等恶性特征的有力支持者。它使细胞能够避免复制性衰老并实现无限的复制潜能。本综述总结了TERT的经典和非经典功能,并讨论了它们如何促进癌症标志。了解端粒酶在促进癌症标志中的作用,为深入了解癌症发生和发展的潜在机制以及将端粒酶干预作为癌症治疗的可能靶点提供了重要见解。对端粒酶介导的对癌症标志影响的精确分子机制进行更多研究,将有助于开发更有针对性和个性化的癌症治疗方法。

相似文献

1
Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution.端粒酶与癌症特征:调控癌细胞进化的复杂相互作用。
Cancer Lett. 2023 Dec 1;578:216459. doi: 10.1016/j.canlet.2023.216459. Epub 2023 Oct 19.
2
Telomerase: central regulator of all of the hallmarks of cancer.端粒酶:癌症所有标志性特征的核心调控者。
Trends Biochem Sci. 2013 Sep;38(9):426-34. doi: 10.1016/j.tibs.2013.07.001. Epub 2013 Aug 7.
3
Telomerase reverse transcriptase in the regulation of gene expression.端粒酶逆转录酶在基因表达调控中的作用。
BMB Rep. 2014 Jan;47(1):8-14. doi: 10.5483/bmbrep.2014.47.1.284.
4
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.人类癌症中端粒酶转录和端粒酶活性激活的机制:旧演员和新角色。
Oncogene. 2019 Aug;38(34):6172-6183. doi: 10.1038/s41388-019-0872-9. Epub 2019 Jul 8.
5
Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.端粒酶逆转录酶的反馈调节:对癌症中端粒酶不断发展领域的新见解。
Cell Signal. 2013 Dec;25(12):2462-8. doi: 10.1016/j.cellsig.2013.08.009. Epub 2013 Aug 29.
6
The regulations of telomerase reverse transcriptase (TERT) in cancer.端粒酶逆转录酶(TERT)在癌症中的调控
Cell Death Dis. 2024 Jan 26;15(1):90. doi: 10.1038/s41419-024-06454-7.
7
Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness.端粒酶逆转录酶激活 miR500A 的转录,抑制 Hedgehog 信号通路并促进细胞侵袭性。
Mol Oncol. 2021 Jul;15(7):1818-1834. doi: 10.1002/1878-0261.12943. Epub 2021 May 2.
8
Telomeres, telomerase and colorectal cancer.端粒、端粒酶与结直肠癌
World J Gastroenterol. 2014 Feb 28;20(8):1940-50. doi: 10.3748/wjg.v20.i8.1940.
9
Cellular functions of the dual-targeted catalytic subunit of telomerase, telomerase reverse transcriptase--potential role in senescence and aging.端粒酶双靶向催化亚基端粒酶逆转录酶的细胞功能——在衰老和老化中的潜在作用
Exp Gerontol. 2014 Aug;56:189-93. doi: 10.1016/j.exger.2014.02.011. Epub 2014 Feb 28.
10
Telomerase Biology Associations Offer Keys to Cancer and Aging Therapeutics.端粒酶生物学关联为癌症和衰老治疗提供关键线索。
Curr Aging Sci. 2020;13(1):11-21. doi: 10.2174/1874609812666190620124324.

引用本文的文献

1
Broad-spectrum antitumor analysis of the telomerase activity inhibitor TPCH derived from the human constitutively expressed protein LPTS/PinX1.源自人类组成性表达蛋白LPTS/PinX1的端粒酶活性抑制剂TPCH的广谱抗肿瘤分析
Front Oncol. 2025 Aug 15;15:1643155. doi: 10.3389/fonc.2025.1643155. eCollection 2025.
2
Development of a microarray based telomerase binding assay reveals unusual binding of a cytochalasin derivative.基于微阵列的端粒酶结合检测方法的开发揭示了一种细胞松弛素衍生物的异常结合。
Sci Rep. 2025 Jun 4;15(1):19515. doi: 10.1038/s41598-025-00230-z.
3
TERT promoter methylation predicts overall survival, immune cell infiltration and response to immunotherapy in clear cell renal cell carcinoma.
端粒酶逆转录酶(TERT)启动子甲基化可预测透明细胞肾细胞癌的总生存期、免疫细胞浸润及对免疫治疗的反应。
Clin Epigenetics. 2025 May 30;17(1):88. doi: 10.1186/s13148-025-01897-x.
4
Viral oncogenesis in cancer: from mechanisms to therapeutics.癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
5
Beyond Telomeres: Unveiling the Extratelomeric Functions of TERT in B-Cell Malignancies.超越端粒:揭示端粒酶逆转录酶在B细胞恶性肿瘤中的端粒外功能
Cancers (Basel). 2025 Mar 30;17(7):1165. doi: 10.3390/cancers17071165.
6
Assessment of telomerase expression in melanoma and cutaneous squamous cell carcinoma: correlation with clinical parameters.黑色素瘤和皮肤鳞状细胞癌中端粒酶表达的评估:与临床参数的相关性
Clin Transl Oncol. 2025 Mar 13. doi: 10.1007/s12094-025-03876-3.
7
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
8
Rolling Circle Amplification Integrating with Exonuclease-III-Assisted Color Reaction for Sensitive Telomerase Activity Analysis.滚环扩增结合核酸外切酶III辅助显色反应用于灵敏的端粒酶活性分析
ACS Omega. 2024 Dec 4;9(50):49081-49087. doi: 10.1021/acsomega.4c03839. eCollection 2024 Dec 17.
9
Radiofrequency ablation: mechanisms and clinical applications.射频消融:机制与临床应用
MedComm (2020). 2024 Oct 2;5(10):e746. doi: 10.1002/mco2.746. eCollection 2024 Oct.
10
ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway.ACYP2 通过抑制 TERT 和 KCNN4/ERK 通路的活性,作为一种创新的纳米治疗靶点,抑制肝癌的进展。
J Nanobiotechnology. 2024 Sep 12;22(1):557. doi: 10.1186/s12951-024-02827-4.